| Release date: December 2008 Expiration date: December 31, 2009 Estimated time to complete activity: 1.25 hours |
Read through all material and click "BEGIN ACTIVITY" at the bottom of the page. |
- Javascript-enabled browser
- Active Internet connection
- Adobe Acrobat Reader
- Adobe Flash Player plugin v.8.0+
Co-sponsored by the University of Chicago Pritzker School of Medicine and Curatio CME Institute
Activity Overview
Given the constantly changing landscape of ulcerative colitis (UC) management, it is essential that clinicians be aware of the continually evolving data and controversies in this area so as to provide optimal care for patients with this lifelong, potentially debilitating disease. This activity is designed to highlight current issues in the treatment of UC.
Target Audience
This activity has been designed to meet the educational needs of gastroenterologists and other health care providers involved in the care of patients with UC.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Define the American College of Gastroenterology Practice Guidelines as they relate to the goal of effective management of UC
- Discuss factors to consider when classifying disease severity and identify optimal treatment strategies for patients with mild or moderate UC
- Discuss the role of 5-aminosalicylic acid in the treatment of patients who require biologic or immunomodulator therapy
- Compare the concept of “bottom-up” vs “top-down” treatment as it relates to UC and discuss the evidence and issues regarding each strategy
- Relate the potential risks of intensive therapy vs the potential risks of colectomy for patients with severe UC
- Design therapeutic strategies to optimize the use of therapies for the management of mild, moderate, or severe UC, for both induction of remission and maintenance and to reduce the risk of complications for patients with UC
Stephen B. Hanauer, MD—Activity Chair View biography
Professor of Medicine and Clinical Pharmacology
Chief, Section of Gastroenterology and Nutrition
University of Chicago Pritzker School of Medicine
Chicago, Illinois
Steering Committee
Maria T. Abreu, MD View biography
Professor of Medicine
Chief, Division of Gastroenterology
University of Miami Miller School of Medicine
Miami, Florida
Sunanda V. Kane, MD, MSPH View biography
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Mayo Clinic
Rochester, Minnesota
Asher A. Kornbluth, MD View biography
Clinical Professor of Medicine
The Henry D. Janowitz Division of Gastroenterology
Mount Sinai School of Medicine
New York, New York
William J. Sandborn, MD View biography
Vice Chairman, Division of Gastroenterology and Hepatology
Professor of Medicine
Mayo Clinic
Rochester, Minnesota
Accreditation Statement
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
The University of Chicago Pritzker School of Medicine designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants should not claim credit for this activity if credit was previously claimed for the live programs on which this activity is based.
Method of Participation
There are no fees for participating in this CME activity. To receive credit during the period December 2008 to December 31, 2009, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, (3) complete the posttest, and (4) complete the activity evaluation form, including the certificate information section.
To obtain a certificate, participants must receive a score of 70% or better on the posttest. The posttest can be accessed at the end of the activity. Please e-mail any questions to cmeinfo@curatiocme.com.
Medium
The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.
Disclosure
The University of Chicago Pritzker School of Medicine and Curatio CME Institute adhere to the ACCME Essential Areas, Standards for Commercial Support, and Policies regarding industry support of continuing medical education. Disclosure of the commercial relationships of everyone in a position to control the content of this educational activity will be made at the activity. Speakers are also required to openly disclose discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Relationship information for the Activity Chair and Faculty Presenter appears below:
Stephen B. Hanauer, MD has disclosed the following relevant financial relationships:
| Consultant: | Abbott, Bristol-Myers Squibb, Centocor, Elan, Ferring, Millennium Pharmaceuticals, Procter & Gamble Pharmaceuticals, Prometheus, Salix, Shire, UCB |
| Clinical Research: | Abbott, Centocor, Elan, Ferring, Procter & Gamble Pharmaceuticals, Prometheus, Salix, Shire, UCB |
| Speaker: | Centocor, Ferring, Procter & Gamble Pharmaceuticals, Prometheus, Salix, UCB |
Relationship information for the Steering Committee appears below:
Maria T. Abreu, MD has disclosed the following relevant financial relationships:
| Speaker: | Abbott, Procter & Gamble Pharmaceuticals, Salix |
Sunanda V. Kane, MD, MSPH has disclosed the following relevant financial relationships:
| Consultant: | Elan, Procter & Gamble Pharmaceuticals, Shire, UCB |
| Research: | Elan, Shire, UCB |
Asher A. Kornbluth, MD has disclosed the following relevant financial relationships:
| Consultant: | Centocor, Elan, Given Imaging, PDL, Procter & Gamble Pharmaceuticals, Prometheus, Salix, Shire, UCB |
| Research Support: | Abbott, Centocor, Given Imaging, Procter & Gamble Pharmaceuticals, Salix, UCB |
| Speakers Bureau: | Abbott, Procter & Gamble Pharmaceuticals, Salix, Shire, UCB |
William J. Sandborn, MD has disclosed the following relevant financial relationships:
| Consultant: | Centocor, Procter & Gamble Pharmaceuticals, Salix, Shire |
| Investigator : | Centocor, Procter & Gamble Pharmaceuticals, Shire |
Disclaimer
The information presented at this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.
Unapproved Product Use
This educational activity may contain discussion of published or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute, Procter & Gamble Pharmaceuticals, and the University of Chicago Pritzker School of Medicine do not recommend the use of any agent outside the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute, Procter & Gamble Pharmaceuticals, or the University of Chicago Pritzker School of Medicine. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Policy on Privacy and Confidentiality
Curatio CME Institute collects the information provided by the user. The information is used to notify users about upcoming programs and educational information that may be of interest. The information is not shared or used for commercial purposes unless prior permission has been granted by the user.
Curatio CME Institute may collect standard Web traffic data such as time and date of visit. Curatio CME Institute uses this information to administer its Web site. Browsing activity is recorded to form aggregate and anonymous demographic information, which is used as described above. Curatio CME Institute does not sell or offer to sell any user data, including registration and billing information, to any third parties for commercial purposes. Curatio CME Institute does, when required, provide the minimum subset of information to third parties that are responsible for accreditation of and issuance of certification for CME/CE tests. By participating in the Web-based activity, the user agrees that Curatio CME Institute has full permission to provide this minimum subset of information to the third parties as required by law.
For CME questions, please contact cmeinfo@curatiocme.com or call (610) 363-1619 ext. 113. If you experience technical difficulties, please contact helpdesk@axis-healthcare.com.